Icon

RASUVO (nda205776)- (7.5MG/0.15ML (7.5MG/0.15ML),10MG/0.20ML (10MG/0.20ML),12.5MG/0.25ML (12.5MG/0.25ML),15MG/0.30ML (15MG/0.30ML),17.5MG/0.35ML (17.5MG/0.35ML),20MG/0.4ML (20MG/0.4ML),22.5MG/0.45ML (22.5MG/0.45ML),25MG/0.5ML (25MG/0.5ML),27.5MG/0.55ML (27.5MG/0.55ML),30MG/0.6ML (30MG/0.6ML))

METHOTREXATE MEDEXUS
7.5MG/0.15ML (7.5MG/0.15ML),10MG/0.20ML (10MG/0.20ML),12.5MG/0.25ML (12.5MG/0.25ML),15MG/0.30ML (15MG/0.30ML),17.5MG/0.35ML (17.5MG/0.35ML),20MG/0.4ML (20MG/0.4ML),22.5MG/0.45ML (22.5MG/0.45ML),25MG/0.5ML (25MG/0.5ML),27.5MG/0.55ML (27.5MG/0.55ML),30MG/0.6ML (30MG/0.6ML)
No Yes
2029-Jun-01 Expired
None None
None No
Rasuvo is a folate analog metabolic inhibitor indicated for the: • Management of patients with severe, active rheumatoid arthritis (RA) and polyarticular juvenile idiopathic arthritis (pJIA), who are intolerant of or had an inadequate response to first-line therapy. • Symptomatic control of severe, recalcitrant, disabling psoriasis in adults who are not adequately responsive to other forms of therapy.
0 0 0
Total Other Developers 1
Drugs with Suitability No
7.5MG/0.15ML (7.5MG/0.15ML) ** ** - - -
10MG/0.20ML (10MG/0.20ML) ** ** - - -
12.5MG/0.25ML (12.5MG/0.25ML) ** ** - - -
15MG/0.30ML (15MG/0.30ML) ** ** Up - -
17.5MG/0.35ML (17.5MG/0.35ML) ** ** - - -
20MG/0.4ML (20MG/0.4ML) ** ** Up - -
22.5MG/0.45ML (22.5MG/0.45ML) ** ** - - -
25MG/0.5ML (25MG/0.5ML) ** ** Up - -
27.5MG/0.55ML (27.5MG/0.55ML) ** ** - - -
30MG/0.6ML (30MG/0.6ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.